⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BEAM News
Beam Therapeutics Inc. Common Stock
Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine
globenewswire.com
BEAM
KNOB CREEK® DEBUTS BLENDER'S EDITION, A LIMITED SERIES CELEBRATING THE ART OF BLENDING
prnewswire.com
BEAM
Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development
globenewswire.com
BEAM
Sickle Cell Care Reaches an Inflection Point as Gene Therapy Enthusiasm Rises, but Referral Pathways and Uptake Lag Amid Due to Treatment Burden
globenewswire.com
NVO
AGIO
BEAM
EDIT
SNY
PFE
MAKER'S MARK UNVEILS 2026 WOOD FINISHING SERIES: THE STEWARDS RELEASE
prnewswire.com
BEAM
Form 8-K
sec.gov
BEAM
Protego Biopharma Appoints John M. Maraganore, Ph.D., to Board of Directors
prnewswire.com
ALNY
BIIB
BEAM
Form 8-K
sec.gov
BEAM
Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)
globenewswire.com
BEAM
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street
globenewswire.com
BEAM